loadpatents
name:-0.026078939437866
name:-0.033453941345215
name:-0.00097203254699707
Golub; Lorne M. Patent Filings

Golub; Lorne M.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Golub; Lorne M..The latest application filed is for "chemically modified curcumins for use in the production of lipoxins".

Company Profile
0.26.23
  • Golub; Lorne M. - Smithtown NY
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Chemically Modified Curcumins For Use In The Production Of Lipoxins
App 20210322346 - Gu; Ying ;   et al.
2021-10-21
Chemically Modified Curcumins For Use In The Production Of Lipoxins
App 20180036262 - Gu; Ying ;   et al.
2018-02-08
Polyenolic zinc-binding agents (pezbins) actively promote inactivation of cancer stem cells and potentiate cytotoxic anti-tumor drug substances
Grant 9,675,576 - Golub , et al. June 13, 2
2017-06-13
Novel Modified Curcumins And Their Uses
App 20160355465 - GOLUB; Lorne M. ;   et al.
2016-12-08
Polyenolic Zinc-binding Agents (pezbins) Actively Promote Inactivation Of Cancer Stem Cells And Potentiate Cytotoxic Anti-tumor Drug Substances
App 20160213638 - GOLUB; Lorne M. ;   et al.
2016-07-28
Polyenolic zinc-binding agents (pezbins) actively promote inactivation of cancer stem cells and potentiate cytotoxic anti-tumor drug substances
Grant 9,220,695 - Golub , et al. December 29, 2
2015-12-29
Polyenolic Zinc-binding Agents (pezbins) Actively Promote Inactivation Of Cancer Stem Cells And Potentiate Cytotoxic Anti-tumor Drug Substances
App 20150150834 - Golub; Lorne M. ;   et al.
2015-06-04
Chemically Modified Curcumins As Inhibitors Of Anthrax Lethal Factor
App 20150073021 - ANTONELLI; Anthony ;   et al.
2015-03-12
Novel Modified Curcumins And Their Uses
App 20140275271 - Golub; Lorne M. ;   et al.
2014-09-18
Methods Of Reducing The Risk Of Cardiovascular Disease In Postmenopausal Women
App 20120046249 - Golub; Lorne M. ;   et al.
2012-02-23
Use of Low Dose Chemically Modified Tetracylines to Reduce Inflammatory Mediators
App 20080249072 - Golub; Lorne M. ;   et al.
2008-10-09
Use of non-antibacterial tetracycline analogs and formulations thereof for the treatment of bacterial exotoxins
App 20080233151 - Golub; Lorne M. ;   et al.
2008-09-25
Use of non-antibacterial tetracycline formulations for inhibiting bacterial spores
App 20070015739 - Walker; Stephen G. ;   et al.
2007-01-18
Use of non-antibacterial tetracycline formulations for inhibiting bacterial spores from becoming infectious vegetative cells
App 20070015738 - Walker; Stephen G. ;   et al.
2007-01-18
Method for reducing c-rective protein levels with non-antibacterial tetracycline formulations
App 20050282786 - Brown, David ;   et al.
2005-12-22
Methods of treating eczema
App 20050148552 - Ryan, Maria Emanuel ;   et al.
2005-07-07
Inhibitor of cataract formation
Grant 6,914,057 - Ryan , et al. July 5, 2
2005-07-05
Method for decreasing low density lipoprotein
Grant 6,841,547 - Brown , et al. January 11, 2
2005-01-11
Method for decreasing low density lipoprotein
App 20040171591 - Brown, David ;   et al.
2004-09-02
Method of treating sepsis-induced ARDS
App 20040092491 - Nieman, Gary ;   et al.
2004-05-13
Use of non-antibacterial tetracycline analogs and formulations thereof for the treatment of bacterial exotoxins
App 20040014731 - Golub, Lorne M. ;   et al.
2004-01-22
Method of inhibiting membrane-type matrix metalloproteinase
App 20020045603 - Golub, Lorne M. ;   et al.
2002-04-18
Method of inhibiting membrane-type matrix metalloproteinase
Grant 6,277,061 - Golub , et al. August 21, 2
2001-08-21
Method of inhibiting cancer growth
Grant 6,100,248 - Golub , et al. August 8, 2
2000-08-08
Method of using tetracycline compounds to enhance interleukin-10 production
Grant 6,015,804 - Golub , et al. January 18, 2
2000-01-18
Combination of bisphosphonate and tetracycline
Grant 5,998,390 - Ramamurthy , et al. December 7, 1
1999-12-07
Method of preventing acute lung injury
Grant 5,977,091 - Nieman , et al. November 2, 1
1999-11-02
Method for inhibiting expression of inducible nitric oxide synthase with tetracycline
Grant 5,919,775 - Amin , et al. July 6, 1
1999-07-06
Method of inhibiting cancer growth
Grant 5,837,696 - Golub , et al. November 17, 1
1998-11-17
Treatment of aortic and vascular aneurysms with tetracycline compounds
Grant 5,834,449 - Thompson , et al. November 10, 1
1998-11-10
Method of using tetracycline compounds for inhibition of endogenous nitric oxide production
Grant 5,789,395 - Amin , et al. August 4, 1
1998-08-04
Non-antibacterial tetracycline compositions of the prevention and treatment of root caries
Grant 5,770,588 - McNamara , et al. June 23, 1
1998-06-23
Tetracyclines including non-antimicrobial chemically-modified tetracyclines inhibit excessive glycosylation of different types of collagen and other proteins during diabetes
Grant 5,532,227 - Golub , et al. July 2, 1
1996-07-02
Inhibition of excessive phospholipase A.sub.2 activity and/or production by non-antimicrobial tetracyclines
Grant 5,523,297 - Pruzanski , et al. June 4, 1
1996-06-04
Composition comprising indomethacin [non-steroidal anti-inflammatory agent] and effectively non-antibacterial tetracycline to reduce bone loss
Grant 5,459,135 - Golub , et al. October 17, 1
1995-10-17
Use of tetracycline to enhance bone protein synthesis and/or treatment of bone deficiency
Grant RE34,656 - Golub , et al. July 5, 1
1994-07-05
Composition comprising fluriprofen and effectively non-antibacterial tetracycline to reduce bone loss
Grant 5,321,017 - Golub , et al. June 14, 1
1994-06-14
Composition comprising non-steroidal anti-inflammatory agent tenidap and effectively non-antibacterial tetracycline
Grant 5,308,839 - Golub , et al. May 3, 1
1994-05-03
Method to reduce connective tissue destruction
Grant 5,258,371 - Golub , et al. November 2, 1
1993-11-02
Non-antibacterial tetracycline compositions possessing anti-collagenolytic properties and methods of preparing and using same
Grant 4,935,411 - McNamara , et al. June 19, 1
1990-06-19
Use of tetracycline to enhance bone protein synthesis and/or treatment of osteoporosis
Grant 4,925,833 - McNamara , et al. May 15, 1
1990-05-15
Non-antibacterial tetracycline compositions possessing anti-collagenolytic properties and methods of preparing and using same
Grant 4,704,383 - McNamara , et al. November 3, 1
1987-11-03
Inhibition of mammalian collagenolytic enzymes by tetracyclines
Grant 4,666,897 - Golub , et al. May 19, 1
1987-05-19

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed